3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
12
Lymphoma, B-Cell
10
Recurrence
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Lymphoma, Non-Hodgkin
8
Multiple Myeloma
5
Lymphoma, Mantle-Cell
5
Burkitt Lymphoma
5
Lymphoma, Follicular
4
Lymphoma
4
Neoplasms
3
Neoplasm, Residual
3
Leukemia, Myeloid, Acute
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Lymphoma, B-Cell, Marginal Zone
2
Breast Neoplasms
2
Solid Tumors
1
Sarcoma, Synovial
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Pyloric Stenosis, Hypertrophic
1
Platinum-Resistant Ovarian Carcinoma
1
Plasmacytoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Nasopharyngeal Carcinoma
1
Mesothelioma, Malignant
1
Meningeal Carcinomatosis
1
Interventions
Oxaliplatin
27
Fluorouracil
23
Leucovorin
22
Cetuximab
22
Bevacizumab
21
Nivolumab
16
Capecitabine
16
Irinotecan
15
pembrolizumab
11
Magnetic Resonance Spectroscopy
11
Specimen Handling
10
encorafenib
8
Folfox protocol
7
trifluridine tipiracil drug combination
6
Ipilimumab
6
Exercise
6
fludarabine
5
cemiplimab
5
Trastuzumab
5
Gemcitabine
5
Cyclophosphamide
5
Cisplatin
5
Blood Specimen Collection
5
Biopsy
5
regorafenib
4
pertuzumab
4
adagrasib
4
Trifluridine
4
Pemetrexed
4
Immune Checkpoint Inhibitors
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
Immunotherapy, Adoptive
×
1 year
×
Clear all
No trials found.